Work

Preliminary Phase II Results of SGN-30 (Anti-CD30 Monoclonal Antibody) in Patients with Cutaneous Anaplastic Large Cell Lymphoma (ALCL).

Year: 2005

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v106.11.4802.4802

Authors: Madeleine Duvic, Joy Kunishige, Youn H. Kim, Andres Foreno-Torres, Lauren C. Pinter-Brown, Mark U. Rarick, John Zic, Sophie M. Worobec, Francine Foss, Karen Flessland, Jeremy Barton

Institutions: Kaiser Permanente, The University of Texas MD Anderson Cancer Center, University of California, Los Angeles, University of Alabama, Vanderbilt University, University of Alabama at Birmingham, University of Illinois Chicago, Stanford University

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2550221932

FWCI: 1.264

Cites:

Cited by: 3

Related to: 10